Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Viral Vector Production Market, by Type
1.4.2 LAMEA Viral Vector Production Market, by Indication
1.4.3 LAMEA Viral Vector Production Market, by Application
1.4.4 LAMEA Viral Vector Production Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter’s Five Forces Analysis
Chapter 4. Strategies Deployed in Viral Vector Production Market
Chapter 5. LAMEA Viral Vector Production Market, by Type
5.1 LAMEA Adeno-Associated Viral Vectors Market, by Country
5.2 LAMEA Lentiviral Vectors Market, by Country
5.3 LAMEA Adenoviral Vectors Market, by Country
5.4 LAMEA Retroviral Vectors Market, by Country
5.5 LAMEA Others Market, by Country
Chapter 6. LAMEA Viral Vector Production Market, by Indication
6.1 LAMEA Cancer Market, by Country
6.2 LAMEA Genetic Disorders Market, by Country
6.3 LAMEA Infectious Diseases Market, by Country
6.4 LAMEA Others Market, by Country
Chapter 7. LAMEA Viral Vector Production Market, by Application
7.1 LAMEA Gene Therapy Market, by Country
7.2 LAMEA Vaccinology Market, by Country
Chapter 8. LAMEA Viral Vector Production Market, by Country
8.1 Brazil Viral Vector Production Market
8.1.1 Brazil Viral Vector Production Market, by Type
8.1.2 Brazil Viral Vector Production Market, by Indication
8.1.3 Brazil Viral Vector Production Market, by Application
8.2 Argentina Viral Vector Production Market
8.2.1 Argentina Viral Vector Production Market, by Type
8.2.2 Argentina Viral Vector Production Market, by Indication
8.2.3 Argentina Viral Vector Production Market, by Application
8.3 UAE Viral Vector Production Market
8.3.1 UAE Viral Vector Production Market, by Type
8.3.2 UAE Viral Vector Production Market, by Indication
8.3.3 UAE Viral Vector Production Market, by Application
8.4 Saudi Arabia Viral Vector Production Market
8.4.1 Saudi Arabia Viral Vector Production Market, by Type
8.4.2 Saudi Arabia Viral Vector Production Market, by Indication
8.4.3 Saudi Arabia Viral Vector Production Market, by Application
8.5 South Africa Viral Vector Production Market
8.5.1 South Africa Viral Vector Production Market, by Type
8.5.2 South Africa Viral Vector Production Market, by Indication
8.5.3 South Africa Viral Vector Production Market, by Application
8.6 Nigeria Viral Vector Production Market
8.6.1 Nigeria Viral Vector Production Market, by Type
8.6.2 Nigeria Viral Vector Production Market, by Indication
8.6.3 Nigeria Viral Vector Production Market, by Application
8.7 Rest of LAMEA Viral Vector Production Market
8.7.1 Rest of LAMEA Viral Vector Production Market, by Type
8.7.2 Rest of LAMEA Viral Vector Production Market, by Indication
8.7.3 Rest of LAMEA Viral Vector Production Market, by Application
Chapter 9. Company Profiles
9.1 Andelyn Biosciences, Inc.
9.1.1 Company Overview
9.1.2 Recent strategies and developments:
9.1.2.1 Partnerships, Collaborations, and Agreements:
9.1.2.2 Geographical Expansions:
9.2 Charles River Laboratories International, Inc.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Recent strategies and developments:
9.2.4.1 Product Launches and Product Expansions:
9.2.4.2 Acquisition and Mergers:
9.2.4.3 Geographical Expansions:
9.2.5 SWOT Analysis
9.3 Danaher Corporation
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 SWOT Analysis
9.4 FinVector Oy (Ferring Ventures S/A)
9.4.1 Company Overview
9.5 Thermo Fisher Scientific, Inc.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expenses
9.5.5 Recent strategies and developments:
9.5.5.1 Acquisition and Mergers:
9.5.5.2 Geographical Expansions:
9.5.6 SWOT Analysis
9.6 Novartis AG
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.6.5 SWOT Analysis
9.7 Takara Bio Inc. (Takara Holdings Inc.)
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.8 Avid Bioservices, Inc.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Recent strategies and developments:
9.8.3.1 Geographical Expansions:
9.9 Oxford Biomedica plc
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expenses
9.9.5 Recent strategies and developments:
9.9.5.1 Partnerships, Collaborations, and Agreements:
9.9.5.2 Product Launches and Product Expansions:
9.10. Lonza Group Ltd.
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
9.10.4 Research & Development Expenses
9.10.5 SWOT Analysis
Unique Offerings 